diclofenac and aprepitant

diclofenac has been researched along with aprepitant in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Natsume, T; Ogawa, S; Takamatsu, H1
Hafez, HM; Mohamed, MZ; Rifaai, RA; Waz, S1

Reviews

1 review(s) available for diclofenac and aprepitant

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for diclofenac and aprepitant

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
[Pharmacological profile of a novel nonhuman primate model of knee osteoarthritis].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2018, Volume: 152, Issue:3

    Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aprepitant; Diclofenac; Duloxetine Hydrochloride; Knee Joint; Morphine; Neurokinin-1 Receptor Antagonists; Osteoarthritis, Knee; Pain; Primates; Serotonin and Noradrenaline Reuptake Inhibitors

2018
Involvement of NOX-4/JAK/STAT pathway in the protective effect of aprepitant against diclofenac-induced renal toxicity.
    Life sciences, 2022, Apr-01, Volume: 294

    Topics: Animals; Aprepitant; Cyclooxygenase Inhibitors; Diclofenac; Gene Expression Regulation; Janus Kinase 1; Male; NADPH Oxidase 4; Neurokinin-1 Receptor Antagonists; Protective Agents; Rats; Rats, Wistar; Renal Insufficiency; STAT3 Transcription Factor

2022